| 000 | 01603 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514014635.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTashiro, H | |
| 245 | 0 | 0 |
_a[Treatment outcomes with vinorelbine for metastatic breast cancer patients previously treated with both doxorubicin and docetaxel]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cOct 2001 |
||
| 300 |
_a1397-401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xanalogs & derivatives |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aSonoda, K | |
| 700 | 1 | _aOhshiro, T | |
| 700 | 1 | _aOhta, M | |
| 700 | 1 | _aYamamura, S | |
| 700 | 1 | _aIshikawa, T | |
| 700 | 1 | _aItasaka, H | |
| 700 | 1 | _aMatsusaka, T | |
| 700 | 1 | _aKume, K | |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 28 _gno. 10 _gp. 1397-401 |
|
| 999 |
_c11598215 _d11598215 |
||